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ABSRACT 
Diabetes-associated oxidative stress causes glomerular hypertrophy, decrease of glo-
merular filtration rate and inhibits cell proliferation that lead to the decrease of renal 
function as indiated by the increase of serum creatinine level and the presence of 
protein in urine. Mahogany seed (Swietenia macrophylla King) has been proven to have 
antidiabetic activity. This study was conducted to evaluate the effect of the ethanolic 
extract of mahogany seeds on the renal function of streptozotocin-induced diabetic rats. 
Six normal rats as control (Group I) and 24 diabetic rats were used in this study. The 
diabetic rats were randomized allocated into four groups with six rats in each group. 
Group II was considered as diabetic rats control and received aquadest. Group III-V were 
considered as extract administered diabetic group and received ethanolic extract of S. 
macrophylla seed for 21 days at a dose of 50, 100 and 200 mg/kg BW, respectively. 
Serum malondialdehyde (MDA), serum creatinine, and urine protein levels were monitored, 
before and after the ethanolic extract of S. macrophylla seed administration. Serum MDA, 
serum creatinine and urine protein levels of all rats after STZ induction (Group II-V) were 
significantly higher than without STZ induction (p < 0.05). A significant decrease in the 
serum MDA and serum creatinine as well as urine protein levels were observed after the 
treatment with ethanolic extract of S. macrophylla seed compared to before treatment 
(p < 0.05). In conclusion, the ethanolic extract of S. macrophylla seed is able to correct 
renal dysfunction of streptozotocin-induced diabetic rats.
ABSTRAK
Stres oksidatif akibat diabetes dapat menyebabkan hipertropi glomerulus, penurunan 
kecepatan filtrasi glomerulus dan penghambatan proliferasi sel yang berakibat terjadinya 
penurunan fungsi ginjal sebagaimana ditunjukkan dengan penurunan kreatinin serum dan 
adanya urin protein. Biji mahoni (Swietenia macrophylla King) terbukti mempunyai aktivitas 
antidiabetes. Penelitian ini dilakuan untuk mengkaji efek ekstrak etanol biji mahoni pada 
fungsi ginjal tikus diabetes yang diinduksi streptozotosin. Enam tikus normal sebagai 
kontrol (Kelompok I) dan 24 tikus diabetes digunakan dalam penelitian. Tikus diabetes 
dibagi menjadi 4 kelompok secara random dengan 6 ekor tikus masing-masing kelompok. 
Kelompok II sebagai kontrol tikus diabetes menerima air suling. Kelompok III-V sebagai 
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kelompok perlakuan menerima ekstrak etanol biji mahoni (S. macrophylla King) selama 21 
hari dengan dosis berturut-turut 50, 100 dan 200 mg/kg BB. Kadar malodehaldehid (MDA) 
serum, kreatinin serum dan protein urin diukur sebelum dan sesudah pemberian ekstrak 
etanol biji mahoni. Kadar MDA serum, kreatinin serum dan protein urin pada semua tikus 
setelah induksi STZ (Group II-V) lebih tinggi secara bermakna dibandingkan tanpa induksi 
STZ (p<0,05). Penurunan secara nyata terhadap kadar MDA serum, kreatinin serum dan 
protein urin dijumpai setelah pemberian ekstrak etanol S. macrophylla King dibandingkan 
sebelum pemberian (p<0,05). Kesimpulan, ekstrak etanol biji mahoni dapat memperbaiki 
disfungsi ginjal tikus diabetes yang diinduksi streptozotosin. 
Key words : hyperglycemia, Swietenia macrophylla King, serum creatinine, MDA, urine 
protein
INTRODUCTION
Diabetes mellitus (DM) is a metabolic 
disease characterized by hyperglycemia due 
to a decrease in insulin secretion, insulin 
action, or both.1 Complications of diabetes 
due to hyperglycemia includes macrovascular 
(coronary artery disease, peripheral arterial 
disease, and stroke) and microvascular 
(diabetic nephropathy, neuropathy, and 
retinopathy) dysfunctions.2 Oxidative stress 
caused by hyperglycemia plays an important 
role in those macrovascular and microvascular 
complications of DM.2,3 Oxidative stress 
occurs as result of the increase of peroxidation 
product as a mediator of tissue damage and 
leads to the activation of pathogenesis 
complication pathways of DM.3
Malondialdehyde (MDA) is a product 
of lipid peroxidation due to the increase of 
reactive oxygen species (ROS) level on the 
oxidative stress conditions. Plasma MDA is 
frequently used as biomarker for oxidative 
stress. In diabetics condition, plasma MDA 
level increases due to the decrease of 
antioxidant level and leads the early systemic 
complications of diabetes as expressed by 
the increased AGEs, protein, lipid serum, 
lymphocytes, and urine of diabetic patients.4,5 
Moreover, oxidative stress causes glomerular 
hypertrophy, decrease of glomerular filtration 
rate and inhibits cell proliferation that lead to 
the decrease of renal function as indiated by 
the increase of serum creatinine level and the 
presence of protein in urine.5-7 
Previous studies showed the benefits and 
potential of some medicinal plants in dealing 
with oxidative stress in both the treatment 
of diabetes and its complication.8 Mahogany 
(Swietenia macrophylla King) was proven 
to have antidiabetic activity. The aqueous-
methanolic extract of the mahogany seed 
induces the pancreatic β cells regeneration 
and increases the insulin production due to 
its antioxidant activity through glucose auto-
oxidant and protein glycation pathways.9 In 
addition, the alcoholic mahogany seed extract 
stimulates the glucokinase enzyme, a major 
catalyst in the posporilation of glucose, in 
lowering blood glucose levels.10
Streptozotocin (STZ) is widely used to 
induce experimental both insulin-dependent 
and non-insulin-dependent diabetes mellitus 
in animals, respectively.  The mechanism of 
STZ action in β cells has been intensively 
investigated and is well understood.11 
Streptozotocin entering the B cell via a glucose 
transporter (GLUT2) causes DNA damage 
due to alkylation of DNA. The DNA damage 
induces activation of poly ADP-ribosylation 
leads to depletion of cellular NAD+ and ATP 
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resulting in the formation of ROS. Moreover, 
STZ liberates toxic amounts of nitric oxide 
that inhibits aconitase activity and participates 
in DNA damage. As a result of the STZ action, 
β cells undergo the destruction by necrosis.12,13
The present study was designed to 
evaluate the effects of the ethanolic extract 
of mahogany seeds (S. macrophylla King) on 
the renal function of streptozotocin-induced 
diabetic rats. The renal function was expressed 
by  serum creatinine and urinary protein levels. 
Furthermore, the plasma MDA level after the 
ethanolic administration was also evaluated.  
MATERIALS AND METHODS
Ethanolic extract preparation
The S. macrophylla King seeds were 
collected in The Bogor Botanical Gardens, 
Indonesia and identified by a botanist in The 
Faculty of Pharmacy, Universitas Gadjah 
Mada Yogyakarta. The seeds were separated 
from the fruits, dried under open air conditions 
and powdered using a blender. The powdered 
seeds were extracted with ethanol by the 
ethanol method for three days. The extract 
was filtered through Whatman filter and the 
filtrate was collected and concentrated in a 
rotary evaporator at 40 oC. The concentrated 
extract was dried under open air and stored 
under refrigeration until further use.    
Induction of diabetes by streptozotocin 
Wistar strain male albino rats, 6-8 weeks of 
age, weighing from 180 to 200 g were selected 
for this study. All rats were acclimated for a 
period of 7 days in our laboratory condition 
prior to the study. Rats were housed at room 
temperature under 12 hours cycles of dark and 
light and were fed standard food and water ad 
libitum. Induction of diabetes in the rats were 
performed by a single intraperitoneal injection 
of STZ at dose of 60 mg/kg BW in 0.1 mL of 
freshly citrate buffer (0.01 M and pH = 4.5). 
The day of STZ injection was designated as 
day 0 (D-0). Development of diabetes was 
confirmed by measuring blood glucose level 
four days after STZ injection (D-4). Rats 
with the blood glucose level higher than 200 
mg/dL were considered to be diabetic. The 
diabetic rats were then selected for the study. 
This study has been approved by Medical and 
Health Research Ethics Committee, Faculty 
of Medecine, Universitas Gadjah Mada, 
Yogyakarta.
Animal treatment
Six normal rats and 24 diabetic rats were 
used in this study. The normal rats were 
considered as non diabetic rats control and 
received aquadest (Group I). The diabetic 
rats were randomized allocated into four 
groups with six rats in each group. Group 
II was considered as diabetic rats control 
and received aquadest. Group III-V were 
considered as extract administered diabetic 
group and received ethanolic extract of S. 
macrophylla seed at a dose of 50, 100, and 
200 mg/kg BW, respectively. The ethanolic 
extract was administered one time per day at 
08.00 AM started from day 4 and continued 
for next 21 days. Blood glucose level was 
measured and monitored on day 0 (D-0), 4 
(D-4), 18 (D-18) and 25 (D-25), respectively. 
In addition, serum creatinine, serum MDA 
and urine protein levels were also monitored, 
however only on day 4 (D-4) and 25 (D-25), 
respectively.
Biochemical analysis
A volume of 2 mL orbital sinus blood 
sample was collected from each study rat and 
assayed by standard methods for estimation 
of blood glucose, serum creatinine and MDA 
levels. The blood glucose level was measured 
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by glucose oxidase peroxidase (GOP-PAP) 
method.14 The serum creatinine level was 
measured by Jaffe method15, MDA level 
was measured by TBARS metod16 and urine 
protein level was measured by colorimetric test 
pyrogallon red metod.17 All spectrophotometric 
measurements were carried out in a DR6000 
UV-Visible spectrophotometer (Hach-US).
Statistical analysis 
All the results were expressed as mean 
± standard deviation (SD) for six animals 
in each group. Statistical comparisons were 
performed using one way analysis of variance 
(ANOVA) followed by Post Hoc Tests Least 
Significant Difference (LSD). p-values of 
less than 0.05 were considered to indicate 
statistical significance.
RESULTS 
The effect of ethanolic extract of mahogany 
seeds on  blood glucose level
Blood glucose level of all rats in all groups 
before STZ induction were in normal level 
(TABLE 1). A significant increase in the level 
of blood glucose level was observed four days 
after STZ induction (D-4) when compared to 
before STZ induction (p < 0.05). All rats on 
Group II-V had the blood glucose level higher 
than 200 mg/dL (p > 0.05). Furthermore,  a 
significant decrease in the level of blood 
glucose level was observed 14 (D-18) as 
well as 21 (D-25) days after the treatment 
with ethanolic extract of S. macrophylla seed 
(Group III-V) (p < 0.05). The blood glucose 
levels in diabetic rats of the Group III-V were 
in normal level (<200 mg/mL) on D-18 and 
D-25. In contrast, the blood glucose level in 
diabetic rats of Group II (without treatment 
with the ethanolic extract) remained higher on 
D-18 and D-25 (p > 0.05) (TABLE 1).   
TABLE 1.  Effect of ethanolic extract of S. macrophylla seed on blood glucose levels (mg/dL) in diabetic rats
Group Treatment
Mean ± Standard Deviation
D-0 D-4 D-18 D-25
I Aquadest 82.42 ± 5.24 77.75  ± 3.09 82.73 ± 5.04 84.90 ± 6.75
II STZ + aquadest 74.83 ± 1.81 230.10 ± 2.99 233.48 ± 6.06 234.15 ± 3.23
III STZ + extract 50 mg 74.12 ± 2.55 227.66 ± 8.69 183.28 ± 13.06 145.43 ± 5.83
IV STZ + extract 100 mg 75.76 ± 2.45 230.45 ± 3.74 146.07 ± 14.81 124.57 ± 2.06
V STZ + extract 200 mg 75.31 ± 3.28 230.86 ± 4.30 127.01 ± 23.55 102.92 ± 4.42
D-0: day on STZ induction; D-4: 4 days after STZ induction; D-18: 14 days after administration of ethaolic extract; 
D-25: 21 days after administration of ethanolic extract.
The effect of ethanolic extract of maho-
gany seeds on serum MDA level
Serum MDA level of all rats four days after 
STZ induction (Group II-V) were significantly 
higher than without STZ induction (p < 
0.05) (TABLE 2). A significant decrease in 
the serum MDA level was observed 21 (D-
25) days after the treatment with ethanolic 
extract of S. macrophylla seed (Group III-V) 
compared to before treatment (D-4) (p < 
0.05). No significant difference in the serum 
MDA level was observed on D-4 compared to 
on D-25 in Group II (p > 0.05) (TABLE 2).   
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Group Treatment
Mean ± Deviation Standard
D-4 D-25
I Aquadest 2.27 ± 0.62 1.31 ± 0.13
II STZ + aquadest 8.72 ± 0.64 8.56 ± 0.44
III STZ + extract 50 mg 8.31 ± 0.77 5.23 ± 0.53
IV STZ + extract 100 mg 8.08 ± 0.47 3.71 ± 0.42
V STZ + extract 200 mg 8.22 ± 0.37 2.56 ± 0.35
TABLE 2.  Effect of ethanolic extract of S. macrophylla seed on serum MDA level (mg/dL)
in diabetic rats
D-4: 4 days after STZ induction; D-25: 21 days after administration of ethanolic extract.
The effect of ethanolic extract of mahogany 
seeds on serum creatinine level
Serum creatinine level of all rats four 
days after STZ induction (Group II-V) 
were significantly higher than without STZ 
induction (p < 0.05) (TABLE 3). A significant 
decrease in the serum creatinine level was 
observed 21 (D-25) days after the treatment 
with ethanolic extract of S. macrophylla seed 
(Group III-V) compared to before treatment 
(D-4) (p < 0.05). No significant difference in 
the serum creatinine level was observed on 
D-4 compared to on D-25 in Group II (p > 
0.05) (TABLE 3).   
Group Treatment
Mean ± Deviation Standard
D-4 D-25
I Aquadest 1.26 ± 0.33 0.67 ± 0.04
II STZ + aquadest 3.49 ± 0.15 3.90 ± 0.23
III STZ + extract 50 mg 3.50 ± 0.26 2.12 ± 0.22
IV STZ + extract 100 mg 3.62 ± 0.18 1.37 ± 0.34
V STZ + extract 200 mg 3.56 ± 0.14 0.68 ± 0.09
      D-4: 4 days after STZ induction; D-25: 21 days after administration of ethanolic extract.
TABLE 3.  Effect of ethanolic extract of S. macrophylla seed on serum creatinine level 
(mg/dL) in diabetic rats
Urine protein level of all rats four days after 
STZ induction (Group II-V) were significantly 
higher than without STZ induction (p < 0.05) 
(TABLE 3). A significant decrease in the urine 
protein level was observed 21 (D-25) days 
after the treatment with ethanolic extract of 
S. macrophylla seed (Group III-V) compared 
to before treatment (D-4) (p < 0.05). No 
significant difference in the urine protein level 
was observed on D-4 compared to on D-25 in 
Group II (p > 0.05) (TABLE 4).  
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TABLE 4.  Effect of ethanolic extract of S. macrophylla seed on urine protein level (mg/
dL) on diabetic rats
Group Treatment
Mean ± Deviation Standard
D-4 D-25
I Aquadest 2.27 ± 0.62 1.31 ± 0.13
II STZ + aquadest 8.72 ± 0.64 8.56 ± 0.44
III STZ + extract 50 mg 8.31 ± 0.77 5.23 ± 0.53
IV STZ + extract 100 mg 8.08 ± 0.47 3.71 ± 0.42
V STZ + extract 200 mg 8.22 ± 0.37 2.56 ± 0.35
D-4: 4 days after STZ induction; D-25: 21 days after administration of ethanolic extract.
 
DISCUSSION
In this study, STZ induction resulted in 
a significant increase in blood glucose level 
(Group II-V) compared to the control group 
(Group I). All rats on Group II-V had the 
blood glucose level higher than 200 mg/dL 
indicating the rats became diabetes. Diabetic 
Streptozotocin-induced diabetes has been 
described a useful experimental model to 
study the activity of antidiabetic agents.18 
Streptozoocin destroys β-cells of the pancreas 
and induces hyperglycemia.11-13,19  
After administration of ethanolic extract 
of S. macrophylla seed to the diabetic rats 
on Group III-V for 21 days, a significant 
decrease in blood glucose level was observed 
which was close to the normal level (< 200 
mg/dL). In addition, the antidiabetic effect of 
the ethanolic extract of S. macrophylla seed 
was in a dose-dependent manner (TABLE 
1). The antidiabetic effect of S. macropylla 
seed extract has been previously reported by 
some authors.9,10,17 Its mechanism of action 
as antidiabetic has been also investigated. 
Kalaivanan et al.10 reported that ethanolic 
extract of mahogany seed can increase insulin 
production and stimulate the regeneration of 
β-cells of the pancreas.  Swietenia macropylla 
seed extract was also reported can activate 
the enzyme glucokinase in lowering blood 
glucose levels.9 Moreover, Maiti et al.20  and 
Dewanjee et al.21 have successfully isolated 
swietenine,  a tetranortriterpenoid, from the 
S. macrophylla seeds and have proven its 
hypoglycemic activity in type 2 diabetic rats.
Serum MDA level of rats four days 
after STZ induction significantly higher 
than without STZ induction indicating that 
oxidative stress developed in diabetic rats 
after STZ induction. After administration of 
ethanolic extract of S. macrophylla seed to 
the diabetic rats on Group III-V for 21 days, 
a significant decrease in serum MDA level 
was observed (TABLE 2). It indicates that 
the ethanolic extract of S. macrophylla seed is 
able to correct the diabetes-induced oxidative 
stress. The ethanol extract of S. macrophylla 
seeds was proven to have antioxidant activity 
in the streptozotocin-induced diabetic rats.17 
Furthermore, the antioxidaive compounds 
from S. macropylla have been isolated such 
as swietemacrophyllanin, catechin, and 
epicatechin.22
Serum creatinine and urine protein 
level of rats four days after STZ induction 
significantly higher than without STZ 
induction indicating the decrease of renal 
function. Diabetes-associated oxidative stress 
causes glomerular hypertrophy, decrease of 
glomerular filtration rate and inhibits cell 
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proliferation that lead to the decrease of renal 
function.5-7 After administration of ethanolic 
extract of S. macrophylla seed to the diabetic 
rats on Group III-V for 21 days, a significant 
decrease in serum creatinine and urine protein 
levels were observed (TABLE 3 and 4). It 
clearly demonstrates that the ethanolic extract 
of S. macrophylla seed is able to protect the 
decrease of renal function due to the diabetes-
induced oxidative stress. As explained by 
Debasis et al.9, the renal protective effect of 
the extract of S. macrophylla seed may be 
explained by two ways.  One way may be due 
to the insulinotrophic effect of this extract that 
results correction in blood glucose level that 
prevents the ROS generation by preventing 
glucose autooxidant and by glication. Another 
way may be the presence of antioxidative 
compounds in this extract that lowered the 
levels of end products of free radicals like 
MDA.
CONCLUSION 
In conclusion, the ethanolic extract of 
mahogany seed (S. macropylla King)  is able 
to correct renal dysfunction of streptozotocin-
induced diabetic rats as indicated by the 
decrease of serum creatinine and urine protein 
after administration of this extract. The renal 
protective effect of the ethanolic extract of 
mahogany seed may be due to its antidiabetic 
and antioxidant effects.
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